about
Aspirin, cyclooxygenase inhibition and colorectal cancerRegular use of aspirin and pancreatic cancer risk.Use of NSAIDs for the chemoprevention of colorectal cancerCooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reductionAspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiencyANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progressionPharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesisTNF-α stimulates colonic myofibroblast migration via COX-2 and Hsp27Roles for inflammation and regulatory T cells in colon cancer.Unifying roles for regulatory T cells and inflammation in cancer.Coordinate down-regulation of adenylyl cyclase isoforms and the stimulatory G protein (G(s)) in intestinal epithelial cell differentiation.Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentationAutoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin.Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoidsTNF-α potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2The role of COX-2 in intestinal inflammation and colorectal cancerRegulation of intracellular cyclooxygenase levels by gene transcription and protein degradationCyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switchTNF-α induces upregulation of EGFR expression and signaling in human colonic myofibroblasts.Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment.Cyclical DNA Methylation and Histone Changes Are Induced by LPS to Activate COX-2 in Human Intestinal Epithelial Cells.15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerUrinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Mechanisms of disease: Inflammatory mediators and cancer prevention.Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer.In Vitro and in Vivo Anticancer Activity of Pardaxin against Proliferation and Growth of Oral Squamous Cell Carcinoma.An inflammatory mediator, prostaglandin E2, in colorectal cancer.Pro-inflammatory prostaglandins and progression of colorectal cancerRepression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.Gut bacteria and cancerThe Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal CancerCyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.Global tumor RNA expression in early establishment of experimental tumor growth and related angiogenesis following COX-inhibition evaluated by microarray analysis.
P2860
Q24598813-FA644E4E-CC2D-439A-BB63-F802E7A91815Q24801805-C342A02C-F150-4AEB-B104-965BF7A700FAQ28165741-4BADF918-6433-4E1F-B2F9-C89B3AD9373DQ28196336-2CD4D5FB-3BC1-489D-9352-A0F21382CCADQ28210586-CCB3EADA-27B8-4305-A029-147EF02E026AQ28248772-DDAD760B-F63D-462A-8A21-D71015C93406Q28481397-9F932895-F9E4-4168-A130-2C75FFF3986EQ33565290-DCCEB466-C621-4729-9B87-3B45288ECA40Q33796554-1434428A-A1D7-4136-BBAD-8A94CA5E1E8BQ33796559-706A250D-3BB6-40A1-8A90-A0834064F6C2Q33800004-D5DB2370-9C24-4C3F-8396-A2C9F8E82BAAQ33819279-AA3B8CB5-1F7C-4AC2-9EBD-B617424BD08DQ34488862-EB45BBEC-92BC-4867-8464-6297FD0091F2Q34663857-594DAE25-DA3D-4E8A-8601-2ECA6AC7FF0EQ34746098-DCB2B8C9-426E-4D8C-88BD-26AB9AA947A7Q34784001-D5B8161F-FFCA-49F4-A1F7-F7D46572398CQ35011895-92C505EC-A3C1-47B1-B96D-892AAF7C340FQ35043366-807E1C3D-198F-42C1-BF8E-F7DD515223A1Q35171200-BECFE8EA-827A-4654-A235-4A17AE4BA2E9Q35234704-5270E24C-F5BE-4AC8-B643-D9B98B99C12BQ35660728-7395F5B4-037A-4436-8D55-716BFF182FF9Q35732971-5B7E4ECB-B279-4C3D-A600-53BEBB888243Q35970190-44F577FF-8CAF-4A3B-AC73-4DFCE88F345CQ36012329-787D26F3-0719-442B-BB59-09BE29FCF7E4Q36020274-5243FE7F-7602-4D69-8672-A53C583CD17EQ36033937-ED460163-2868-4BD9-BDFA-D1CAC4E61D65Q36038028-BE1C9323-0A0D-4646-9835-5BEFE757469FQ36143603-948EC082-E406-4F5B-8B92-0E6739C11CD8Q36228506-E8F6014E-4DB5-466C-A016-63F6A8C7516AQ36248969-56E5CAA7-12EC-4741-B219-8F123E72C8FDQ36303978-73254C08-7F5F-4337-80A4-2E3E24EC5A2FQ36499761-A582C91C-97AA-4A5D-8E7C-97351F7363F5Q36507098-EF183201-B6E6-409F-90E5-845C7DB87CC8Q36701908-7430E4F1-9095-411F-B817-081CA560BF2CQ36909506-834DA49D-09AE-4C04-9180-393F45FE320DQ37067304-ADC3AD47-BE47-417E-92FB-84AA14A927F5Q37082877-E90B7E64-DE8D-4936-A3D8-A472CAC157F6Q37148157-0CE45A2C-6944-49CD-B4C9-489DB29BE05BQ37150765-F40339E2-E74B-4A7D-9051-05F3F282AAB6Q37175930-699ACC06-2762-480C-BEDD-7D1C6BDD6C50
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
COX-2: a target for colon cancer prevention.
@ast
COX-2: a target for colon cancer prevention.
@en
COX-2: a target for colon cancer prevention.
@nl
type
label
COX-2: a target for colon cancer prevention.
@ast
COX-2: a target for colon cancer prevention.
@en
COX-2: a target for colon cancer prevention.
@nl
prefLabel
COX-2: a target for colon cancer prevention.
@ast
COX-2: a target for colon cancer prevention.
@en
COX-2: a target for colon cancer prevention.
@nl
P1476
COX-2: a target for colon cancer prevention.
@en
P2093
Lawrence J Marnett
Raymond N DuBois
P356
10.1146/ANNUREV.PHARMTOX.42.082301.164620
P577
2002-01-01T00:00:00Z